# DAS181 in Patients With Parainfluenza

> **NCT01441024** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Parainfluenza Infection

## Interventions

- **DRUG:** DAS181
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01441024
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-07-14
- **Primary completion:** 2014-02-27
- **Final completion:** 2014-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441024, "DAS181 in Patients With Parainfluenza". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01441024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*